1,3-Benzodioxolyl-N-ethylbutanamine

1,3-Benzodioxolyl-N-ethylbutanamine
Names
Preferred IUPAC name
1-(2H-1,3-Benzodioxol-5-yl)-N-ethylbutan-2-amine
Other names
3,4-Methenedioxy-α,N-diethyl-phenethylamine; 3,4-Methylenedioxy-N-ethylbutanphenamine; MDEB
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C13H19NO2/c1-3-11(14-4-2)7-10-5-6-12-13(8-10)16-9-15-12/h5-6,8,11,14H,3-4,7,9H2,1-2H3
    Key: IYZPKSQJPVUWRO-UHFFFAOYSA-N
  • InChI=1/C13H19NO2/c1-3-11(14-4-2)7-10-5-6-12-13(8-10)16-9-15-12/h5-6,8,11,14H,3-4,7,9H2,1-2H3
    Key: IYZPKSQJPVUWRO-UHFFFAOYAT
  • O1c2ccc(cc2OC1)CC(NCC)CC
Properties
C13H19NO2
Molar mass 221.300 g·mol−1
Melting point 176 to 177 °C (349 to 351 °F; 449 to 450 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Ethylbenzodioxolylbutanamine (EBDB; Ethyl-J) is a lesser-known entactogen, stimulant, and psychedelic of the phenethylamine, amphetamine, and phenylisobutylamine families. It is the N-ethyl analogue of benzodioxylbutanamine (BDB; "J"), and also the α-ethyl analogue of methylenedioxyethylamphetamine (MDEA; "Eve").

EBDB was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage consumed was 90 mg, and the duration is unknown.[1] EBDB produced few to no effects at the dosage range tested in PiHKAL, but at higher doses of several hundred milligrams it produces euphoric effects similar to those of methylbenzodioxylbutanamine (MBDB; "Eden", "Methyl-J"), although milder and shorter lasting.[citation needed]

Very little data exists about the pharmacological properties, metabolism, and toxicity of EBDB.

See also

References

  1. ^ Ethyl-J Entry in PiHKAL


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.